Pfizer Collaborates with Nodality to Streamline Autoimmune Disease Drug Development
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)
Published: 15 Aug-2012
DOI: 10.3833/pdr.v2012.i8.1790 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Pfizer has formed a multiyear collaboration with Nodality to use the latter’s single cell network profiling (SCNP) technology as a tool to streamline the development of new compounds for autoimmune diseases, beginning with lupus...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS